Table 4. LHANS - top 20 active ingredients in descending order of consumption - 2022 vs 2021.
DDD: Defined Daily Dose
Description | LHANS | Change % 2022 vs 2021 | ||
DDDx1000 inhabitants/day | Gross expenditure x 1000 inhabitants/day | DDD x 1000 inhabitants/day | Gross expenditure x 1000 inhabitants/day | |
Amoxicillin | 0.85 | 0.53 | 5.5% | 4.6% |
Amoxicillin and beta-lactamase inhibitor | 7.23 | 11.22 | 22.1% | 20.1% |
Azithromycin | 3.39 | 5.37 | 10.8% | 3.5% |
Cefaclor | 0.05 | 0.10 | 29.8% | 24.4% |
Cefditoren | 0.56 | 2.18 | - 7.9 % | - 73.6 % |
Cefixime | 1.68 | 4.39 | 44.9% | 44.8% |
Ceftazidime | 0.06 | 1.22 | 5.1% | 6.6% |
Ceftriaxone | 0.66 | 8.83 | 8.2% | 6.7% |
Cefuroxime | 0.06 | 0.09 | - 3.3 % | - 3.4 % |
Ciprofloxacin | 1.46 | 4.16 | 6.0 % | 5.1% |
Clarithromycin | 3.18 | 3.29 | 49.5% | 51.3% |
Doxycycline | 0.17 | 0.07 | - 0.7 % | - 1.2 % |
Fosfomycin | 0.54 | 2.80 | 0.3% | - 0.6 % |
Levofloxacin | 1.15 | 1.86 | 5.4% | 1.6% |
Limecycline | 0.14 | 0.13 | - 13.3 % | - 13.8 % |
Minocycline | 0.07 | 0.09 | - 3.7 % | - 4.3 % |
Nitrofurantoin | 0.28 | 0.28 | - 0.9 % | - 1.9 % |
Prulifloxacin | 0.12 | 0.53 | - 10.9 % | - 13.6 % |
Roxithromycin | 0.16 | 0.43 | 47.6% | 46.8% |
Sulfamethoxazol and trimethoprim | 0.39 | 0.20 | 0.1% | - 1.3 % |